Golf: Blistering finish earns Redman share of early lead

FAN Editor
PGA: Travelers Championship - Final Round
FILE PHOTO: Jun 28, 2020; Cromwell, Connecticut, USA; Doc Redman plays from the fairway on the second hole during the final round of the Travelers Championship golf tournament at TPC River Highlands. Mandatory Credit: Bill Streicher-USA TODAY Sports

July 2, 2020

(Reuters) – Doc Redman collected seven birdies in his last eight holes to grab a share of the early first-round lead with Scott Stallings at the Rocket Mortgage Classic in Detroit on Thursday.

Redman, runner-up at last year’s Mortgage Classic and still chasing a first PGA Tour win, made a quiet start at the Detroit Golf Club, picking up a single birdie on his outward nine.

But after taking his only bogey of the round at the 10th, the 22-year-old caught fire by carding birdies the rest of the way home except the par-five 14th for a seven-under 65.

Stallings got off to a birdie/bogey start but was error free the rest of the way, capping his round with back-to-back birdies to join fellow American Redman atop the leaderboard.

Lurking one back on six under 66 were Americans Peter Malnati and Chase Seiffert, and Argentine Emiliano Grillo.

Rickie Fowler headlines a group two behind at five under while world number six Webb Simpson, the highest-ranked player in the field, returned a four-under 68 to sit three off the pace.

Simpson won last month’s RBC Heritage in Hilton Head, South Carolina but pulled out of the Travelers Championship after his daughter, who later tested negative, showed symptoms of COVID-19.

The fourth PGA Tour event since the season returned from its coronavirus shutdown, the tournament is being played without fans. A sixth player, American Chad Campbell, tested positive for COVID-19 on Tuesday.

(Reporting by Steve Keating in Toronto, Editing by Ed Osmond)

Free America Network Articles

Leave a Reply

Next Post

Moderna stock falls by as much as 9.4% after report says late-stage coronavirus vaccine trial delayed

Moderna‘s stock fell by as much as 9.4% in midday trading Thursday after a report said the biotech company’s late-stage trial for a potential coronavirus vaccine will be delayed, possibly by a few weeks. The company, which is working with the National Institutes of Health, was expected to begin a phase 3 […]

You May Like